pSS subjects with evidence of pure sensory neuropathies, including SFN and DRG, are usually characterized by a low prevalence of serological markers of chronic B-cell activation, including ANA, anti-Ro/SSA, anti-La/SSB and rheumatoid factor (14–16, 21, 24–36). This evidence concerns the gene SSB and sensory peripheral neuropathy.